Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Nitazoxanide evaluated in viral respiratory infections

Nov. 8, 2011

Phase III results show immunogenicity of quadrivalent flu vaccine in children

Nov. 8, 2011

Promising data described from several trials of natalizumab in RRMS

Nov. 8, 2011

Shigamabs well tolerated to date in phase II trial

Nov. 7, 2011

Study compares Merck & Co. 15-valent pneumococcal conjugate vaccine to Prevnar

Nov. 7, 2011

Two PentaStaph vaccine components are immunogenic in phase I/II testing

Nov. 7, 2011

Final results available of first OvaSave trial in Crohn's disease

Nov. 7, 2011

Findings reported from REFLEX and MOSAIC trials of IFN-beta1a

Nov. 7, 2011

Ondansetron is effective in treating diarrhea-predominant irritable bowel syndrome

Nov. 4, 2011

Boceprevir improves hepatitis C treatment in patients coinfected with HIV

Nov. 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...